Hyloris Pharmaceuticals SaEURONEXT: HYL

Hyloris Pharmaceuticals Receives Exclusive License Option for Innovative Topical Therapy for a Rare Genetic Skin Disorder

· Issued by Hyloris Pharmaceuticals SA

11 Dec 2025 17:52 CET

Subscribe
Issuer

HYLORIS PHARMACEUTICALS SA

hylorislicense-option-topical-therapyen.pdf

Source

HYLORIS

Provider

Euronext

Company Name

HYLORIS

ISIN

BE0974363955

Symbol

HYL

Market

Euronext

Earlier from Hyloris Pharmaceuticals Sa

All Hyloris Pharmaceuticals Sa news releases